XML 67 R28.htm IDEA: XBRL DOCUMENT v3.22.0.1
Convertible preferred stock and members's/stockholders' equity (deficit) (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Common Stock Warrants As of December 31, 2021 the remaining common stock warrants below are exercisable and expire as follows:

 

Outstanding and exercisable

 

Exercise price per share

 

 

Expiration date

151,088

 

$

132.37

 

 

March 12, 2022

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense recognized for all equity awards under the 2020 Plan has been reported in the consolidated statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Year ended
December 31,
2021

 

 

Year ended
December 31,
2020

 

Research and development

 

$

4,688

 

 

$

740

 

General and administrative

 

 

20,429

 

 

 

2,282

 

Total

 

$

25,117

 

 

$

3,022

 

Summary of Restricted Stock Units

The following table summarizes RSU activity under the 2020 Plan for the years ended December 31, 2021 and 2020:

 

 

 

Number of
Shares

 

 

Weighted -
average
grant date
fair value

 

Outstanding at December 31, 2019

 

 

 

 

$

 

Granted

 

 

1,920,037

 

 

$

18.00

 

Vested

 

 

 

 

$

 

Outstanding at December 31, 2020

 

 

1,920,037

 

 

$

18.00

 

Granted

 

 

 

 

$

 

Vested

 

 

944,991

 

 

$

18.00

 

Outstanding at December 31, 2021

 

 

975,046

 

 

$

18.00

 

Summary of Stock Option Activity

The following table summarizes stock option activity under the 2020 Plan for the year ended December 31, 2021 and 2020 (in thousands, except share and per option data and years):

 

 

 

Number of
options

 

 

Weighted -
average
exercise
price per
option

 

 

Weighted -
average
remaining
contractual
term
(in years)

 

 

Aggregate
intrinsic
value

 

Balance at December 31, 2019

 

 

 

 

$

 

 

 

 

 

$

 

Granted

 

 

615,106

 

 

$

18.00

 

 

 

 

 

 

 

Balance at December 31, 2020

 

 

615,106

 

 

$

18.00

 

 

9.95

 

 

$

9,848

 

Granted

 

 

479,543

 

 

$

37.86

 

 

 

 

 

 

 

Exercised

 

 

(7,747

)

 

$

18.00

 

 

 

 

 

$

182,829

 

Balance at December 31, 2021

 

 

1,086,902

 

 

$

26.76

 

 

 

9.22

 

 

$

991,495

 

Vested and expected to vest at December 31, 2021

 

 

1,086,902

 

 

$

26.76

 

 

 

9.22

 

 

$

991,495

 

Exercisable at December 31, 2021

 

 

155,579

 

 

$

18.31

 

 

 

8.97

 

 

$

247,486

 

Summary of Assumptions Used in Black-Scholes Model

The assumptions used in the Black-Scholes option pricing model to determine the fair value of stock option grants were as follows:

 

 

 

Year ended
December 31,
2021

 

 

Year ended
December 31,
2020

 

Expected volatility

 

 

74.7

%

 

 

74.5

%

Risk-free interest rate

 

 

1.06

%

 

 

0.52

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Expected term

 

5.98 years

 

 

6.09 years

 

Schedule of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance are as follows in common equivalent shares:

 

 

 

December 31,
2021

 

 

December 31,
2020

 

Warrants for the purchase of common stock

 

 

151,088

 

 

 

717,674

 

Common stock options and restricted stock units issued and outstanding

 

 

2,061,948

 

 

 

2,535,143

 

Awards available for future issuance under the 2020 Plan

 

 

3,211,854

 

 

 

2,404,535

 

Awards available for future issuance under the ESPP

 

 

822,811

 

 

 

464,829

 

Total common stock reserved for future issuance

 

 

6,247,701

 

 

 

6,122,181